NeoGenomics wraps up takeover of liquid biopsy platform company Inivata
NeoGenomics, a US-based cancer diagnostics and pharma services company, has wrapped up its previously announced $390 million takeover of Inivata, a liquid biopsy platform company based in Cambridge, England. The deal was announced in May 2021 by NeoGenomics as it exercised a purchase option to acquire the remaining equity interest in Inivata. A year prior […]